Factors Associated with Dengue Shock Syndrome: A Systematic Review and Meta-Analysis

PLoS Neglected Tropical Diseases

Volumn 7, Issue 9, 2013, Pages

  Huy, Nguyen Tien ^a   Van Giang, Tran ^a   Thuy, Dinh Ha Duy ^b   Kikuchi, Mihoko ^a   Hien, Tran Tinh ^c   Zamora, Javier ^d   Hirayama, Kenji ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b PharmaCo Cell Co Ltd   (Japan)

^c OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^d HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FIBRINOGEN;

AGE; ARTICLE; ASCITES; DENGUE; DENGUE VIRUS 2; DIGESTIVE SYSTEM DISEASE; DISEASE ASSOCIATION; GENDER; HEMOCONCENTRATION; HEMORRHAGIC FEVER; HEPATOMEGALY; HUMAN; HYPOALBUMINEMIA; HYPOPROTEINEMIA; MALNUTRITION; META ANALYSIS; NEUROLOGIC DISEASE; PARTIAL THROMBOPLASTIN TIME; PLEURA EFFUSION; PREVALENCE; PRIMARY INFECTION; PROTHROMBIN TIME; SECONDARY INFECTION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; THROMBOCYTOPENIA;

ANIMALS; ASIA, SOUTHEASTERN; DENGUE VIRUS; HUMANS; INCIDENCE; RISK FACTORS; SEROTYPING; SEVERE DENGUE;

EID: 84884696789     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002412     Document Type: Article

References (73)

1. Gibbons RV, Vaughn DW, (2002) Dengue: an escalating problem. Bmj 324: 1563-1566.
2. WHO (1997) World Health Organization. Dengue haemorrhagic fever: Diagnosis, treatment, prevention and control. Geneva: World Health Organization.
3. WHO (2009) World Health Organization. Guidelines for diagnosis, treatment, prevention and control; Organization WH, editor. Geneva: World Health Organization.
4. Anders KL, Nguyet NM, Chau NV, Hung NT, Thuy TT, et al. (2011) Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam. Am J Trop Med Hyg 84: 127-134.
5. Gubler DJ, (2011) Dengue, Urbanization and Globalization: The Unholy Trinity of the 21(st) Century. Trop Med Health 39: 3-11.
6. Wilder-Smith A, Ooi EE, Vasudevan SG, Gubler DJ, (2010) Update on dengue: epidemiology, virus evolution, antiviral drugs, and vaccine development. Curr Infect Dis Rep 12: 157-164.
7. Kalayanarooj S, (2011) Clinical Manifestations and Management of Dengue/DHF/DSS. Trop Med Health 39: 83-87.
8. Al-Muhandis N, Hunter PR, (2011) The value of educational messages embedded in a community-based approach to combat dengue Fever: a systematic review and meta regression analysis. PLoS Negl Trop Dis 5: e1278.
9. Martina BE, Koraka P, Osterhaus AD, (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564-581.
10. Ha TT, Huy NT, Murao LA, Lan NT, Thuy TT, et al. (2011) Elevated levels of cell-free circulating DNA in patients with acute dengue virus infection. PLoS One 6: e25969.
11. Srikiatkhachorn A, Green S, (2010) Markers of dengue disease severity. Curr Top Microbiol Immunol 338: 67-82.
12. McBride WJ, Bielefeldt-Ohmann H, (2000) Dengue viral infections; pathogenesis and epidemiology. Microbes Infect 2: 1041-1050.
13. Ranjit S, Kissoon N, (2011) Dengue hemorrhagic fever and shock syndromes. Pediatr Crit Care Med 12: 90-100.
14. Guzman MG, Halstead SB, Artsob H, Buchy P, Farrar J, et al. (2010) Dengue: a continuing global threat. Nat Rev Microbiol 8: S7-16.
15. Kalayanarooj S, Nimmannitya S, (2005) Is dengue severity related to nutritional status? Southeast Asian J Trop Med Public Health 36: 378-384.
16. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62: e1-34.
17. Lan NT, Hirayama K, (2011) Host genetic susceptibility to severe dengue infection. Trop Med Health 39: 73-81.
18. Nguyen TP, Kikuchi M, Vu TQ, Do QH, Tran TT, et al. (2008) Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis 2: e304.
19. Pai M, McCulloch M, Enanoria W, Colford JM Jr, (2004) Systematic reviews of diagnostic test evaluations: What's behind the scenes? ACP J Club 141: A11-13.
20. Wells GA, Shea B, O'Connell D, Petersen J, Welch V, et al. (2010) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. http://wwwohrica/programs/clinical_epidemiology/oxfordhtm.
21. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to Meta-Analysis. Chapter 7: Converting Among Effect Sizes: John Wiley and Sons, Ltd, Chichester, UK.
22. Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2005) Comprehensive meta-analysis version 2. Englewood, NJ: Biostat.
23. Munafo MR, Flint J, (2004) Meta-analysis of genetic association studies. Trends Genet 20: 439-444.
24. Zintzaras E, Lau J, (2008) Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol 61: 634-645.
25. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. Bmj 327: 557-560.
26. Thompson SG, Higgins JP, (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21: 1559-1573.
27. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
28. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L, (2006) Comparison of two methods to detect publication bias in meta-analysis. Jama 295: 676-680.
29. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. Bmj 315: 629-634.
30. Duval S, Tweedie R, (2000) Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56: 455-463.
31. Mengoli C, Cruciani M, Barnes RA, Loeffler J, Donnelly JP, (2009) Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 9: 89-96.
32. Perneger TV, (1998) What's wrong with Bonferroni adjustments. Bmj 316: 1236-1238.
33. Nakagawa S, (2004) A farewell to Bonferroni: the problems of low statistical power and publication bias. Behavioral Ecology 15: 1044-1045.
34. Greenland S, Longnecker MP, (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135: 1301-1309.
35. Irving HM, Samokhvalov AV, Rehm J, (2009) Alcohol as a risk factor for pancreatitis. A systematic review and meta-analysis. Jop 10: 387-392.
36. Bagiella E, Sloan RP, Heitjan DF, (2000) Mixed-effects models in psychophysiology. Psychophysiology 37: 13-20.
37. Akaike H, (1974) A new look at the statistical model identification. IEEE Transactions on Automatic Control 19: 716-723.
38. Glaziou P, Chungue E, Gestas P, Soulignac O, Couter JP, et al. (1992) Dengue fever and dengue shock syndrome in French Polynesia. Southeast Asian J Trop Med Public Health 23: 531-532.
39. Kittigul L, Pitakarnjanakul P, Sujirarat D, Siripanichgon K, (2007) The differences of clinical manifestations and laboratory findings in children and adults with dengue virus infection. J Clin Virol 39: 76-81.
40. Hanafusa S, Chanyasanha C, Sujirarat D, Khuankhunsathid I, Yaguchi A, et al. (2008) Clinical features and differences between child and adult dengue infections in Rayong Province, southeast Thailand. Southeast Asian J Trop Med Public Health 39: 252-259.
41. Balmaseda A, Hammond SN, Perez MA, Cuadra R, Solano S, et al. (2005) Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. Am J Trop Med Hyg 73: 1059-1062.
42. Nimmannitya S, Halstead SB, Cohen SN, Margiotta MR, (1969) Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg 18: 954-971.
43. Cox DR (2006) Combination of data. In Encyclopedia of Statistical Sciences, 2nd edn (eds S. Kotz, C. B. Read, N. Balakrishnan and B. Vidakovic). Hoboken: Wiley. 1074-1081.
44. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
45. Palma S, Delgado-Rodriguez M, (2005) Assessment of publication bias in meta-analyses of cardiovascular diseases. J Epidemiol Community Health 59: 864-869.
46. Cummings DA, Iamsirithaworn S, Lessler JT, McDermott A, Prasanthong R, et al. (2009) The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling. PLoS Med 6: e1000139.
47. Widagdo (2008) Blood zinc levels and clinical severity of dengue hemorrhagic fever in children. Southeast Asian J Trop Med Public Health 39: 610-616.
48. Kabra SK, Jain Y, Pandey RM, Madhulika, Singhal T, et al. (1999) Dengue haemorrhagic fever in children in the 1996 Delhi epidemic. Trans R Soc Trop Med Hyg 93: 294-298.
49. Basuki PS, (2003) A glance at the von Willebrand factor in dengue virus infection. Southeast Asian J Trop Med Public Health 34: 559-563.
50. Junia J, Garna H, Setiabudi D, (2007) Clinical risk factors for dengue shock syndrome in children. Paediatrica Indonesiana 47: 7-11.
51. Tantracheewathorn T, Tantracheewathorn S, (2007) Risk factors of dengue shock syndrome in children. J Med Assoc Thai 90: 272-277.
52. Dewi R, Tumbelaka AR, Sjarif DR, (2006) Clinical features of dengue hemorrhagic fever and risk factors of shock event. Paediatrica Indonesiana 46: 144-148.
53. Nguyen TH, Nguyen TL, Lei HY, Lin YS, Le BL, et al. (2005) Association between sex, nutritional status, severity of dengue hemorrhagic fever, and immune status in infants with dengue hemorrhagic fever. Am J Trop Med Hyg 72: 370-374.
54. Kan EF, Rampengan TH, (2004) Factors associated with shock in children with dengue hemorrhagic fever. Paediatrica Indonesiana 44: 171-175.
55. Pham TB, Nguyen TH, Vu TQ, Nguyen TL, Malvy D, (2007) [Predictive factors of dengue shock syndrome at the children Hospital No. 1, Ho-chi-Minh City, Vietnam]. Bull Soc Pathol Exot 100: 43-47.
56. Kamath SR, Ranjit S, (2006) Clinical features, complications and atypical manifestations of children with severe forms of dengue hemorrhagic fever in South India. Indian J Pediatr 73: 889-895.
57. Khan EF, Rampengan TH, (2004) Factors associated with shock in children with dengue hemorrhagic fever. Paediatrica Indonesiana 44: 171-175.
58. Ray G, Kumar V, Kapoor AK, Dutta AK, Batra S, (1999) Status of antioxidants and other biochemical abnormalities in children with dengue fever. J Trop Pediatr 45: 4-7.
59. Nimmannitya S, (1987) Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 18: 392-397.
60. Cohen SN, Halstead SB, (1966) Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, 1964. J Pediatr 68: 448-456.
61. Pongpanich B, Bhanchet P, Phanichyakarn P, Valyasevi A, (1973) Studies on dengue hemorrhagic fever. Clinical study: an evaluation of steroids as a treatment. J Med Assoc Thai 56: 6-14.
62. Chuansumrit A, Puripokai C, Butthep P, Wongtiraporn W, Sasanakul W, et al. (2010) Laboratory predictors of dengue shock syndrome during the febrile stage. Southeast Asian J Trop Med Public Health 41: 326-332.
63. Chongsrisawat V, Hutagalung Y, Poovorawan Y, (2009) Liver function test results and outcomes in children with acute liver failure due to dengue infection. Southeast Asian J Trop Med Public Health 40: 47-53.
64. Nguyen TH, Lei HY, Nguyen TL, Lin YS, Huang KJ, et al. (2004) Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 189: 221-232.
65. Harris E, Perez L, Phares CR, Perez Mde L, Idiaquez W, et al. (2003) Fluid intake and decreased risk for hospitalization for dengue fever, Nicaragua. Emerg Infect Dis 9: 1003-1006.
66. Guzman MG, Kouri G, Bravo J, Valdes L, Vazquez S, et al. (2002) Effect of age on outcome of secondary dengue 2 infections. Int J Infect Dis 6: 118-124.
67. Halstead SB, (2007) Dengue. Lancet 370: 1644-1652.
68. Gamble J, Bethell D, Day NP, Loc PP, Phu NH, et al. (2000) Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock? Clin Sci (Lond) 98: 211-216.
69. WHO (1999) World Health Organization. Management of severe malnutrition: a manual for physicians and other senior health workers.
70. Murthy JM, (2010) Neurological complication of dengue infection. Neurol India 58: 581-584.
71. Kyle JL, Harris E, (2008) Global spread and persistence of dengue. Annu Rev Microbiol 62: 71-92.
72. Srikiatkhachorn A, Gibbons RV, Green S, Libraty DH, Thomas SJ, et al. (2010) Dengue hemorrhagic fever: the sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005. Clin Infect Dis 50: 1135-1143.
73. da Costa BR, Rutjes AW, Johnston BC, Reichenbach S, Nuesch E, et al. Methods to convert continuous outcomes into odds ratios of treatment response and numbers needed to treat: meta-epidemiological study. Int J Epidemiol 41: 1445-1459.